Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H27N3O4S2.ClH |
| Molecular Weight | 413.984 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)NCCN(C(C)C)S(=O)(=O)C1=CC=C(NS(C)(=O)=O)C=C1
InChI
InChIKey=RFMZRLGPSDNVKE-UHFFFAOYSA-N
InChI=1S/C15H27N3O4S2.ClH/c1-12(2)16-10-11-18(13(3)4)24(21,22)15-8-6-14(7-9-15)17-23(5,19)20;/h6-9,12-13,16-17H,10-11H2,1-5H3;1H
| Molecular Formula | C15H27N3O4S2 |
| Molecular Weight | 377.523 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Risotilide is a Class III antiarrhythmic agent that inhibits the voltage-dependent potassium channel. Risotilide prolongs cardiac action potentials and refractory periods. It was shown to reduce ventricular vulnerability in a study on arrhythmogenic effects of left ventricular hypertrophy (LVH) in the intact heart in cats. Phase I and II trials have been conducted, but development of this drug has been discontinued.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0015269 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2017153 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:02:16 GMT 2025
by
admin
on
Mon Mar 31 18:02:16 GMT 2025
|
| Record UNII |
3S9230SS6Z
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47793
Created by
admin on Mon Mar 31 18:02:16 GMT 2025 , Edited by admin on Mon Mar 31 18:02:16 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2110984
Created by
admin on Mon Mar 31 18:02:16 GMT 2025 , Edited by admin on Mon Mar 31 18:02:16 GMT 2025
|
PRIMARY | |||
|
116907-13-2
Created by
admin on Mon Mar 31 18:02:16 GMT 2025 , Edited by admin on Mon Mar 31 18:02:16 GMT 2025
|
PRIMARY | |||
|
C152231
Created by
admin on Mon Mar 31 18:02:16 GMT 2025 , Edited by admin on Mon Mar 31 18:02:16 GMT 2025
|
PRIMARY | |||
|
DTXSID50151576
Created by
admin on Mon Mar 31 18:02:16 GMT 2025 , Edited by admin on Mon Mar 31 18:02:16 GMT 2025
|
PRIMARY | |||
|
3S9230SS6Z
Created by
admin on Mon Mar 31 18:02:16 GMT 2025 , Edited by admin on Mon Mar 31 18:02:16 GMT 2025
|
PRIMARY | |||
|
60666
Created by
admin on Mon Mar 31 18:02:16 GMT 2025 , Edited by admin on Mon Mar 31 18:02:16 GMT 2025
|
PRIMARY | |||
|
300000055084
Created by
admin on Mon Mar 31 18:02:16 GMT 2025 , Edited by admin on Mon Mar 31 18:02:16 GMT 2025
|
PRIMARY | |||
|
BB-11
Created by
admin on Mon Mar 31 18:02:16 GMT 2025 , Edited by admin on Mon Mar 31 18:02:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |